Plague in guinea pigs and its prevention by subunit vaccines

American Journal of Pathology

Volumn 178, Issue 4, 2011, Pages 1689-1700

  Quenee, Lauriane E ^a,b   Ciletti, Nancy ^a,b   Berube, Bryan ^a   Krausz, Thomas ^a   Elli, Derek ^a,b   Hermanas, Timothy ^a,b   Schneewind, Olaf ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b ARGONNE NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLAGUE VACCINE; RECOMBINANT F1 PROTEIN; RECOMBINANT LCRV PROTEIN; RECOMBINANT PROTEIN; RECOMBINANT V10 PROTEIN; SUBUNIT VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; BACTERIAL VIRULENCE; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG PURIFICATION; DYSPNEA; EPISTAXIS; FEMALE; GUINEA PIG; LUNG INFECTION; LUNG PARENCHYMA; NECROSIS; NONHUMAN; OUTCOME ASSESSMENT; PASSIVE IMMUNIZATION; PLAGUE; PRIORITY JOURNAL; VACCINATION; VACCINE PRODUCTION; YERSINIA PESTIS;

EID: 79953662540     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2010.12.028     Document Type: Article

References (50)

1. Yersin A: La peste bubonique à Hong-Kong. Ann Inst Pasteur 1894, 2:428-430
2. Stenseth NC, Atshabar BB, Begon M, Belmain SR, Bertherat E, Carniel E, Gage KL, Leirs H, Rahalison L: Plague: past, present, and future. PLoS Med 2008, 5:e3
3. Perry RD, Fetherston JD: Yersinia pestis: etiologic agent of plague. Clin Microbiol Rev 1997, 10:35-66 (Pubitemid 27042831)
4. Davis S, Begon M, De Bruyn L, Ageyev VS, Klasovskiy NL, Pole SB, Viljugrein H, Stenseth NC, Leirs H: Predictive thresholds for plague in Khazakhstan. Science 2004, 304:736-738
5. Simond PL: La propagation de la peste. Ann Inst Pasteur 1898, 12:625-687
6. Inglesby TV, Dennis DT, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Friedlander AM, Hauer J, Koerner JF, Layton M, McDade J, Osterholm MT, O'Toole T, Parker G, Perl TM, Russell PK, Schoch-Spana M, Tonat K: Plague as a biological weapon: medical and public health management. JAMA 2000, 283:2281-2290 (Pubitemid 30246781)
7. Boisier P, Rahalison L, Rasolomaharo M, Ratsitorahina M, Mahafaly M, Razafimahefa M, Duplantier J-M, Ratsifasomanana L, Chanteau S: Epidemiologic features of four successive annual outbreaks of bubonic plague in Mahajanga. Madagascar. Emerg Infect Dis 2002, 8:311-316 (Pubitemid 34266270)
8. Meyer K: Pneumonic plague. Bacteriol Rev 1961, 25:249-261
9. Girard JM, Wagner DM, Vogler AJ, Keys C, Allender CJ, Drickamer LC, Keim P: Differential plague-transmission dynamics determine Yersinia pestis population genetic structure on local, regional, and global scales. Proc Natl Acad Sci U S A 2004, 101:8408-8413 (Pubitemid 38736588)
10. Inglesby TV, Grossman R, O'Toole T: A plague on your city: observations from TOPOFF. Clin Infect Dis 2001, 32:436-445 (Pubitemid 32173631)
11. Brubaker RR: The recent emergence of plague: a process of felonious evolution. Microb Ecol 2004, 47:293-299
12. Smiley ST: Current challenges in the development of vaccines for pneumonic plague. Expert Rev Vaccines 2008, 7:209-221
13. Quenee LE, Schneewind O: Plague vaccines and the molecular basis of immunity against Yersinia pestis. Hum Vaccin 2009, 5:817-823
14. Andrews GP, Heath DG, Anderson GW Jr, Welkos SL, Friedlander AM: Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge. Infect Immun 1996, 64:2180-2187
15. Baker EE, Sommer H, Foster LE, Meyer E, Meyer KF: Studies on immunization against plague, I: the isolation and characterization of the soluble antigen of Pasteurella pestis. J Immunol 1952, 68:131-145
16. Burrows TW: An antigen determining virulence in Pasteurella pestis. Nature 1956, 177:426-427
17. Mueller CA, Broz P, Muller SA, Ringler P, Erne-Brand F, Sorg I, Kuhn M, Engel A, Cornelis GR: The V-antigen of Yersinia forms a distinct structure at the tip of injectisome needles. Science 2005, 310:674-676 (Pubitemid 41528159)
18. Heath DG, Anderson GW Jr, Mauro JM, Welkos SL, Andrews GP, Adamovicz JJ, Friedlander AM: Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine. Vaccine 1998, 16:1131-1137 (Pubitemid 28307882)
19. Motin VM, Nedialkov YA, Brubaker RR: V antigen-polyhistidine fusion peptide: binding to LcrH and active immunity against plague. Infect Immun 1996, 64:4313-4318 (Pubitemid 26318158)
20. Quenee L, Cornelius CA, Ciletti NA, Elli D, Schneewind O: Yersinia pestis caf1 (F1) variants and the limits of plague vaccine protection. Infect Immun 2008,76:2025-2036
21. Williamson ED, Flick-Smith HC, LeButt C, Rowland CA, Jones SM, Waters EL, Gwyther RJ, Miller J, Packer PJ, Irving M: Human immune response to a plague vaccine comprising recombinant F1 and V antigens. Infect Immun 2005, 73:3598-3608 (Pubitemid 40745904)
22. Burrows TW, Bacon GA: The effect of loss of different virulence determinants on the virulence and immunogenicity of strains of Pasteurella pestis. Br J Exp Pathol 1958, 39:278-291
23. Davis KJ, Fritz DL, Pitt MLM, Welkos SL, Worsham PL, Friedlander AM: Pathology of experimental pneumonic plague produced by fraction 1-positive and fraction 1-negative Yersinia pestis in African green monkeys (Cercopitheus aethiops). Arch Pathol Lab Med 1996, 120:156-163 (Pubitemid 26058523)
24. DeBord KL, Anderson DM, Marketon MM, Overheim KA, DePaolo RW, Ciletti NA, Jabri B, Schneewind O: Immunogenicity and protective immunity against bubonic and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV. Infect Immun 2006, 74:4910-4914 (Pubitemid 44157279)
25. Sebbane F, Gardner D, Long D, Gowen BB, Hinnebusch BJ: Kinetics of disease progression and host response in a rat model of bubonic plague. Am J Pathol 2005, 166:1427-1439 (Pubitemid 40586513)
26. Anderson DA, Ciletti NA, Lee H, Elli D, Segal J, DeBord KL, Overheim KA, Brubaker RR, Schneewind O: Pneumonic plague pathogenesis and immunity in brown Norway rats. Am J Pathol 2009, 174:910-921
27. Van Andel R, Sherwood R, Gennings C, Lyons CR, Hutt J, Gigliotti A, Barr E: Clinical and pathological features of cynomologus macaques (Macaca fascicularis) infected with aerosolized Yersinia pestis. Comp Med 2008, 58:68-75 (Pubitemid 351413460)
28. Meyer KF, Smith G, Foster L, Brookman M, Sung MH: Live, attenuated Yersinia pestis vaccine: virulent in non-human primates, harmless to guinea pigs. J Infect Dis 1974, 129:S85-S112
29. Fukui GM, Lawton WD, Janssen WA, Surgalla MJ: Response of guinea pig lungs to in vivo and in vitro cultures of Pasteurella pestis. J Infect Dis 1957, 100:103-107
30. Donovan JE, Ham D, Fuki EM, Surgalla MJ: Role of the capsule of Pasteurella pestis in bubonic plague in the guinea pig. J Infect Dis 1961, 109:154-157
31. Girard G: Plague. Annu Rev Microbiol 1955, 9:253-277
32. Feodorova VA, Pan'kina LN, Savostina EP, Sayapina LV, Motin VL, Dentovskaya SV, Shaikhutdinova RZ, Ivanov SA, Lindner B, Kondakova AN, Bystrova OV, Kocharova NA, Senchenkova SN, Holst O, Pier GB, Knirel YA, Anisimov AP: A Yersinia pestis lpxM-mutant live vaccine induces enhanced immunity against bubonic plague in mice and guinea pigs. Vaccine 2007, 25:7620-7628
33. von Metz E, Eisler DM, Hottle GA: Immunogenicity of plague vaccines in mice and guinea pigs. Appl Microbiol 1971, 22:84-88
34. Jones SM, Griffin KF, Hodgson I, Williamson ED: Protective efficacy of a fully recombinant plague vaccine in the guinea pig. Vaccine 2003, 21:3912-3918 (Pubitemid 37338218)
35. Santi L, Giritch A, Roy CJ, Marillonnet S, Klimyuk V, Gleba Y, Webb R, Arntzen CJ, Mason HS: Protection conferred by recombinant Yersinia pestis antigens produced by a rapid and highly scalable plant expression system. Proc Natl Acad Sci U S A 2006, 103:861-866 (Pubitemid 43212188)
36. Friedlander AM, Welkos SL, Worsham PL, Andrews GP, Heath DG, Anderson GW Jr, Pitt LM, Estep J, Davis K: Relationship between virulence and immunity as revealed in recent studies of the F1 capsule of Yersinia pestis. Clin Infect Dis 1995, 21:S178-S181
37. Doll JM, Zeitz PS, Ettestad P, Bucholtz AL, Davis T, Gage KL: Cat-transmitted fatal pneumonic plague in a person who traveled from Colorado to Arizona. Am J Trop Med Hyg 1994, 51:109-114 (Pubitemid 24266296)
38. Parkhill J, Wren BW, Thompson NR, Titball RW, Holden MT, Prentice MB, Sebaihia M, James KD, Churcher C, Mungall KL, Baker S, Dasham D, Bentley SD, Brokks K, Cerdeno-Tarraga AM, Chillingworth T, Cronin A, Davies RM, Davis P, Dougan G, Feltwell T, Hamlin N, Holroyd S, Jagels K, Karlyshev AV, Leather S, Moule S, Oyston PC, Quail M, Rutherford K, Simmonds M, Skelton J, Stevens K, Whitehead S, Barrell BG: Genome sequence of Yersinia pestis, the causative agent of plague. Nature 2001, 413:523-527
39. Cornelius CA, Quenee LE, Elli D, Ciletti NA, Schneewind O: Yersinia pestis IS1541 transposition provides for escape from plague immunity. Infect Immun 2009, 77:1807-1816
40. Studier FW, Rosenberg AH, Dunn JJ, Dubendorff JW: Use of T7 polymerase to direct expression of cloned genes. Methods Enzymol 1990, 185:60-89 (Pubitemid 20219811)
41. Overheim KA, Depaolo RW, Debord KL, Morrin EM, Anderson DM, Green NM, Brubaker RR, Jabri B, Schneewind O: LcrV plague vaccine with altered immunomodulatory properties. Infect Immun 2005, 73:5152-5159 (Pubitemid 41105674)
42. Deng W, Burland V, Plunkett G III, Boutin A, Mayhew GF, Liss P, Perna NT, Rose DJ, Mau B, Zhou S, Schwartz DC, Fetherston JD, Lindler LE, Brubaker RR, Plano GV, Straley SC, McDonough KA, Nilles ML, Matson JS, Blattner FR, Perry RD: Genome sequence of Yersinia pestis KIM. J Bacteriol 2002, 184:4601-4611 (Pubitemid 34832588)
43. Aida Y, Pabst MJ: Removal of endotoxin from protein solutions by phase separation using Triton X-114. J Immunol Methods 1990, 132:191-195 (Pubitemid 20281877)
44. Samoilova SV, Samoilova LV, Yezhov IN, Drozdov IG, Anisimov AP: Virulence of pPst+ and pPst- strains of Yersinia pestis for guinea-pigs. J Med Microbiol 1996, 45:440-444 (Pubitemid 26397969)
45. Cornelius CA, Quenee LE, Elli D, Ciletti NA, Schneewind O: V10 subunit vaccine protects cynomolgus macaques from lethal pneumonic plague. Infect Immun 2008, 76:5588-5597
46. Reed LJ, Muench H: A simple method of estimating fifty per cent endpoints. Am J Hyg 1938, 27:493-497
47. Meyer KF, Quan SF, Larson A: Prophylactic immunization and specific therapy of experimental pneumonic plague. Am Rev Tuberc 1948, 57:312-321
48. Gupta UD, Katoch VM: Animal models of tuberculosis for vaccine development. Indian J Med Res 2009, 129:11-18
49. Winter CC, Cherry WB, Moody MD: An unusual strain of Pasteurella pestis isolated from a fatal case of human plague. Bull WHO 1960, 23:408-409
50. Sebbane F, Jarrett C, Gardner D, Long D, Hinnebusch BJ: The Yersinia pestis caf1M1A1 fimbrial capsule operon promotes transmission by flea bite in a mouse model of bubonic plague. Infect Immun 2009, 77:1222-1229